FDA approves Sarepta’s DMD drug that it had previously rejected
Biogen chalks up another failure
3M sells off its drug delivery business
The House passes the Lower Drug Costs Now Act, but it’s unlikely to become law
*please scroll down for all the latest news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe
